A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network.
Saved in:
| Title: | A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naïve patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network. |
|---|---|
| Authors: | Mross K (AUTHOR), Dittrich C (AUTHOR), Aulitzky WE (AUTHOR), Strumberg D (AUTHOR), Schutte J (AUTHOR), Schmid RM (AUTHOR), Hollerbach S (AUTHOR), Merger M (AUTHOR), Munzert G (AUTHOR), Fleischer F (AUTHOR), Scheulen ME (AUTHOR), Mross, K1 (AUTHOR), Dittrich, C (AUTHOR), Aulitzky, W E (AUTHOR), Strumberg, D (AUTHOR), Schutte, J (AUTHOR), Schmid, R M (AUTHOR), Hollerbach, S (AUTHOR), Merger, M (AUTHOR), Munzert, G (AUTHOR) |
| Source: | British Journal of Cancer. 7/10/2012, Vol. 107 Issue 2, p280-286. 7p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/bjc.2012.257 |
